Sitemap
Pages
- About us
- Consulting Services
- Homepage
- Institute of Management
- Library
- News
- Privacy policy
- Sitemap
- Smart Pharma Care
- Terms of use
Articles par catégorie
- Catégorie : Articles
- Catégorie : Conferences
- Catégorie : Editorial
- Catégorie : Non classé
- Catégorie : Position Papers
- The French Retail Drug Supply & VTOs
- The French OTC Market
- Healthcare Costs Regulation in France
- Economics of French Retail Pharmacies – Situation analysis & trends
- 2024 Half-year Collection
- Pharma Operational Strategy – Survival Toolkit
- The French Food Supplements Market
- Biosimilars Substitution Impact & Strategy
- The French Rare Diseases Market
- Pharma Business Strategy – Survival Toolkit
- The French Biosimilars market
- The French Retail Generics Market
- Anti-Obesity Medications Market
- High Performance Pharma Brand Plans – The 5 Pitfalls to avoid
- Accessing & Convincing Physicians
- Smart Pharma Complete Collection 2016 – 2023
- Pharma Corporate Strategy – Survival Toolkit
- Five pharma marketing solutions to outperform the competition
- Evaluation of pharma distribution alternatives for high-priced drugs on the French retail market
- Personal Brand Optimizer
- Generative AI for pharma companies
- Medical Affairs Best Practices
- High-Performance Strategic Medical Plans
- MSLs Activities & Best Practices
- Five Insights about the Pharma Industry – Truths & Untruths
- Is France Attractive for Pharma Companies – Comparisons & Recommendations
- Smart Pharma Complete Collection 2016 – 2022
- Value of Established Brands – How to get the best of it?
- Generics Manufacturers – Why are they at risk in France?
- Digital Therapeutics – What Opportunities for Pharma Companies?
- Digitalization of the Value Chain – Application to Pharma Companies
- Digital Therapeutics – Challenges for Pharma Companies
- Digital Health & Patient Journey
- What Future for the Orphan Drugs Market? – Strategic Insights
- Dietary Supplement & Baby Care Markets – Key learnings
- Hospital Value-based Procurement
- Smart Pharma Complete Collection 2016 – 2021
- Management & Trainings – 2021 Collection
- Sales Force Effectiveness – 2021 Collection
- Medical Affairs & Marketing – 2021 Collection
- Strategy & Market Access – 2021 Collection
- Pharma Market Insights – 2021 Collection
- How to Boost Corporate Reputation? – A practical guide for pharma companies
- Top 20 Pharma Companies – Performance & Strategy
- What future for medical calls?
- Pharma Strategy at Affiliate Level
- Smart Pharma 2020 Collection
- Omnichannel Strategy in Pharma Marketing – Best practices
- Med Reps Survival post-Covid-19
- Global Pharma Market & Covid-19 Impact – 2019-2024 Perspectives
- Engaging HCPs in Post-Covid-19 Era
- Covid-19 & Business Continuity
- French retail pharmacies – 2019-2023 perspectives
- Service-led Medical Calls
- Outstanding Physician Experience to boost Brand Preference
- Pharma Market Insight Studies
- Catégorie : Report & books
Books
- French Retail Drug Supply & VTOs
- The French OTC Market
- Healthcare Costs Regulation in France
- Economics of French Retail Pharmacies – Situation analysis & trends
- La Visite Médicale "Haute Performance"
- 2024 Half-year Collection
- Pharma Operational Strategy
- The French Food Supplements Market
- Biosimilars Substitution Impact & Strategy
- Rare diseases on the French market
- Pharma Business Strategy
- The French Biosimilars market
- The French retail generics market
- Anti-Obesity Medications Market
- High Performance Pharma Brand Plans – The 5 Pitfalls to avoid
- Accessing & Convincing Physicians
- Medical Affairs Collection
- Pharma Corporate Strategy
- Five Pharma Marketing Solutions
- Evaluation of pharma distribution alternatives for high-priced drugs on the French retail market
- Personal Brand Optimizer
- Generative AI for pharma companies
- Medical Affairs Best Practices
- High-Performance Strategic Medical Plans
- MSLs' activities & best practices – Benchmarking study
- Five Insights about the Pharma Industry - Truths & Untruths
- Is France Attractive for Pharma Companies - Comparisons & Recommendations
- Smart Pharma Complete Collection 2016 - 2023
- Value of Established Brands - How to get the best of it?
- Unique Pharma Conferences for Management Teams
- Generics Manufacturers - Why are they at risk in France?
- Digital Therapeutics - What Opportunities for Pharma Companies?
- Digitalization of the Value Chain – Application to Pharma Companies
- Digital Therapeutics - Challenges for Pharma Companies
- Santé Numérique & Parcours patient
- What Future for the Orphan Drugs Market? - Strategic Insights
- Dietary Supplement & Baby Care Markets - Key learnings
- Hospital Value-based Procurement
- How to Boost Corporate Reputation? - A practical guide for pharma companies
- Top 20 Pharma Companies – Performance & Strategy
- What future for medical calls?
- Pharma Strategy at Affiliate Level
- Omnichannel Strategy in Pharma Marketing - Best Practices
- Med Reps Survival post-Covid-19
- Global Pharma Market & Covid-19 Impact – 2019-2024 Perspectives
- Engaging HCPs in Post-Covid-19 Era
- Covid-19 & Business Continuity
- Service-led Medical Calls
- Outstanding Physician Experience
- The French Pharma Market 2022-2027 (2023)
- Storytelling in Business
- Excellence in Execution
- Strategy & Marketing
- Sales Force Management
- Pharma Training Programs 2025
- The Hidden Part of Smart Pharma
- 2018-2023 Global & French Pharma Markets (2019)
- How can Creativity boost your Performance?
- How to optimize mature Brand Performance?
- Successful Product Launch in the Pharma Sector
- What is the real value of digital pharma marketing?
- Plans d’Actions Régionaux & Sectoriels
- Customer Brand Preference Plan
- The Brand Market Access Plan
- Performance & Organization of most successful mid pharma companies
- Patient-centric strategy
- Create High Impact Interactions with Physicians
- KOL Partnership Model
- Brand Preference optimization
- How to get physicians prefer your brand?
- Concurrence des génériques sur le marché OTC – Perspectives 2020 en France
- 2020 Pharma Trends & Marketing Challenges
- Assurance Maladie Complémentaire en France
- Distribution & Economie de l’officine en France – Perspectives 2020
- Truths & Untruths in the Global Pharma Industry
- Le marché pharmaceutique Mondial – Perspectives 2016 – 2026
- Drug Value & Market Access Optimization
- The French Generics Market – Including Biosimilars (2017)
- Pharma Market Insight Studies (2019)
- Pharma Market Perspectives 2017 – 2023 (2019)
- Succeeding on the French Biosimilars Market (2019)
- Hospital & Institution Relationships in Regions
- Pharma Field Force Organization
- Pharma Strategy Crafting
- Pharma Market Research
- Pharma BD&L
- Hospital KAMs
- Medical Representatives
- Pharma Marketers
- Medical Science Liaisons
- Key Performance & Key Execution Indicators
- Project Management
- Time Management
- Be a Smart Manager – Not just a Good one
- How customer-centricity can increase brand preference?
- Talking up sales
- The brave new world of corporate marketing
- Counting the cost of purchasing
- Heading for change: marketing and sales trends in France
- Changes at the French pharmacy
- Survival strategies in contract sales organizations
- Disease management opportunities in France
- The Evolution of the global pharma industry
- Working with the authorities
- Drug reimbursement harmonisation in Europe
- Le médicament en libre accès : la grande illusion
- Le switch : solution ou danger ?
- Des stratégies opposées pour les « big pharma »
- Automédication : Quel attrait pour le marché mondial ?
- Should big pharma sell their OTC business?
- Thin pickings in dietary supplements
- How bright are the prospects for self-medication in France?
- Assessing the OTC market in France
- What future for the French retail generic market?
- Les génériques, ce n’est plus automatique
- Quelles perspectives pour les génériques?
- Princeps-génériques: faut-il pactiser avec l’ennemi?
- What is the value of authorized generic agreements?
- Barriers to substitution
- How bright is the future for generics?
- Lighting fire from wet timber in French generics market
- Can generics really help to curb French healthcare costs - 1999
- Is the sun rising for Japanese generics?
- Entering the French generics market
- La réputation d’entreprise – Un nouvel enjeu stratégique
- Le BPS, pour la ”justesse de voix”
- Les marques sont-elles condamnées à mourir ?
- Financial requirements of immunisation programmes in developing countries: 2004-2014 perspective
- The end of the back-up brands?
- Making the most of maturity
- Winning strategies in the French hospital market
- Are generic defense strategies worth the effort?
- ACE-inhibitors - an analysis of marketing strategy
- Building prescriber loyalty
- The French Generics Market 2017-2022 prospects (2018)
- Drug Value & Market Access Optimization (2016)
- Pharma Marketing Tool Box (2016)
- Strategic KOL Engagement Planning
Topics
- Articles
- Corporate Strategy & Management
- Customer Strategy & Management
- Keynotes & Conferences
- Management & Organization
- Management Series
- Market Insights
- Market Insights
- Position papers
- Position Papers Collection
- Report & Books
- Strategy – Generic products
- Strategy – OTC & Dietary Supplements
- Strategy R&D – based products
- The Best-in-class Series
- The Medical Series
- The Smart Tool Series